Exploring the Dementia Science

Ian James Martins

Edith Cowan University, Australia

Abstract

Dementia covers a wide range of specific health issues, including Alzheimer disease. The abnormal brain changes cause diseases clustered under the general term "dementia." Such changes cause a deterioration in the ability to think, also known as cognitive abilities, severe enough to hinder everyday life and autonomous function. We also affect behaviour, feelings and relationships. Dementia Conference 2020 is designed to meet the needs of experienced professionals as well as new careers. It would be a group of experts from all over the world from Dementia and Alzheimer disease. Dementia Conference will be a big introduction to Dementia's new findings. It's a great opportunity for everyone to experience international networking and collaborate with world-class experts where we want your generous participation on our board. The goal of much of the research activity in dementia is to develop interventions for 'treatment' or even 'cure'. The classical bench to bedside paradigm has been disappointing in dementia. There is a long list of putative dementia treatment compounds with favourable pre-clinical and early phase trial data that have been neutral or even potentially harmful when assessed in phase III studies. Lewy body dementia is a common but frequently under diagnosed cause of dementia often mistaken for the more familiar entity of Alzheimer disease. Clinically the distinction is important, because it can have profound implications for management. The diagnosis of Lewy body dementia has important implications. It is associated with a high incidence of neuroleptic sensitivity, necessitating great caution in the use of these common antipsychotic agents. Early studies indicate cholinesterase inhibitors can be beneficial for treating the hallucinations and behaviour disturbances that afflict these patients and might also improve cognition. The Majorly Focused Highlights for our Dementia Conference were Dementia: An Underlying Disease, Alzheimers Disease, Parkinson’s Disease, Neurodegenerative Diseases, Vascular Dementia, Neuropharmacology, Neuroepigenetics, Geriatrics Dementia and Cognitive Disorder, Diagnosis and Prognosis of Alzheimer, Bioinformatics Approach for Dementia, Recent Advancements in the Diagnosis of Dementia, Case Reports in Dementia, Treatment Modalities for Dementia, Alternative treatment for Alzheimer, Dementia Care, Practice and Awareness First of all, we extend our sincere gratitude to all of our excellent keynote speakers, speakers, conference attendees, students, associations, media partners, exhibitor and guests whomade Dementia 2019 a successful and victorious event. Allied Academies hosted the event 13thWorld Congress on Dementia and Alzheimer’s Disease during the dates September16-17, 2019 in Holiday Inn, Paris, France with the theme “Exploring the Challenges of the Era of Dementia and Alzheimer's Disease”. Benevolent and active participation from the Editorial Board Members of supporting International Journals as well as from leading academic researchers, Neurologists, Doctors, research scholars, students and leaders from various disciplines in Neuroscience research played a key role in making Dementia 2019 a grand success. The Dementiaconference was marked by the attendance of young and brilliant researchers, business delegates and talented student communities representing various countries, who have driven this event into the path of success. The conference highlighted through various sessions on current neuroscience research. Dementia 2019 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the fields Dementia, Alzheimer’s disease, their treatments, diagnosis, care, other related neurodegenerative diseases etc., The Dementia conference proceedings were carried out through various scientific-sessions and plenary lectures. The conference was embarked with an opening ceremony followed by a series of lectures delivered by thehonourableguests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk and testimonials received from the attendees were: Keynote and Notable Speakers at Dementia 2019: Jan Ricny | National Institute of Mental Health | Czech Republic Azza A Ali | Al-Azhar University | Egypt Zdenka Kristofikova |National Institute of Mental Health | Czech Republic Sandra Garrido | Western Sydney University | Australia Veronica Redaelli | Neurological Institute Carlo Besta | Italy Elena Vasenina |Russian Medical Academy of Postgraduate Education | Russia Fereshteh Bagheri |School of Rehabilitation Sciences | Iran Santiago Restrepo Restrepo |CorporaciónUniversitaria Americana | Colombia The meeting was carried out through various scientific sessions, in which the discussions were held on the following major scientific tracks: Dementia Alzheimer’s Disease Parkinson’s Disease Neurodegenerative Diseases Vascular Dementia Traumatic Brain Injury Neuropharmacology Neuroepigenetics Role of Amyloid Protein in Alzheimer’s and Dementia Bioinformatics Approach for Dementia Recent Advancements in the Diagnosis of Dementia Case Reports in Dementia Treatment Modalities for Dementia Treatment Modalities for Dementia Dementia Care, Practice and Awareness With the grand success of Dementia 2019, Allied Academies is proud to announce the “14thWorld Congress on Dementia and Alzheimer’s Disease” to be held during the dates May 01-02, 2020 in the City of Counts, Barcelona, Spain.